Roy D - Search Results

1

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.

Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, Roy D. Dorian P, et al. Among authors: roy d. Am Heart J. 2002 Jun;143(6):984-90. doi: 10.1067/mhj.2002.122518. Am Heart J. 2002. PMID: 12075253 Clinical Trial.

2

Rate-dependent effects of diltiazem on human atrioventricular nodal properties.

Talajic M, Lemery R, Roy D, Villemaire C, Cartier R, Coutu B, Nattel S. Talajic M, et al. Among authors: roy d. Circulation. 1992 Sep;86(3):870-7. doi: 10.1161/01.cir.86.3.870. Circulation. 1992. PMID: 1516199

3

Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome.

Lemery R, Talajic M, Roy D, Coutu B, Lavoie L, Lavallée E, Cartier R. Lemery R, et al. Among authors: roy d. Circulation. 1992 Mar;85(3):957-62. doi: 10.1161/01.cir.85.3.957. Circulation. 1992. PMID: 1537132

4

Cycle length alternation during supraventricular tachycardia: occurrence and mechanism in a canine model of AV reentrant tachycardia.

Talajic M, Villemaire C, Papadatos D, Lemery R, Roy D, Nattel S. Talajic M, et al. Among authors: roy d. Pacing Clin Electrophysiol. 1990 Mar;13(3):314-25. doi: 10.1111/j.1540-8159.1990.tb02045.x. Pacing Clin Electrophysiol. 1990. PMID: 1690404

5

In vitro and in vivo effects within the coronary sinus of nonarcing and arcing shocks using a new system of low-energy DC ablation.

Lemery R, Leung TK, Lavallée E, Girard A, Talajic M, Roy D, Montpetit M. Lemery R, et al. Among authors: roy d. Circulation. 1991 Jan;83(1):279-93. doi: 10.1161/01.cir.83.1.279. Circulation. 1991. PMID: 1984886

6

Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.

Ranger S, Talajic M, Lemery R, Roy D, Villemaire C, Nattel S. Ranger S, et al. Among authors: roy d. Circulation. 1991 Jun;83(6):1987-94. doi: 10.1161/01.cir.83.6.1987. Circulation. 1991. PMID: 2040051

7

Electrophysiologic evaluation and outcome of patients with syncope of unknown origin.

Muller T, Roy D, Talajic M, Lemery R, Nattel S, Cassidy D. Muller T, et al. Among authors: roy d. Eur Heart J. 1991 Feb;12(2):139-43. doi: 10.1093/oxfordjournals.eurheartj.a059859. Eur Heart J. 1991. PMID: 2044546

8

Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.

Nattel S, Ranger S, Talajic M, Lemery R, Roy D. Nattel S, et al. Among authors: roy d. Am J Med. 1990 Aug;89(2):235-8. doi: 10.1016/0002-9343(90)90305-w. Am J Med. 1990. PMID: 2382671 No abstract available.

9

Sinus node dysfunction and sudden cardiac death following treatment with encainide.

Lemery R, Talajic M, Nattel S, Theroux P, Roy D. Lemery R, et al. Among authors: roy d. Pacing Clin Electrophysiol. 1989 Oct;12(10):1607-12. doi: 10.1111/j.1540-8159.1989.tb01839.x. Pacing Clin Electrophysiol. 1989. PMID: 2477816

10

Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade.

Ranger S, Talajic M, Lemery R, Roy D, Nattel S. Ranger S, et al. Among authors: roy d. Circulation. 1989 May;79(5):1000-6. doi: 10.1161/01.cir.79.5.1000. Circulation. 1989. PMID: 2540920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,751 results

Search Page

Filters